New gene correction therapy for Duchenne muscular dystrophy
Duchenne type muscular dystrophy (DMD) is the most common hereditary muscular disease among children, leaving them wheelchair-bound before the age of twelve and reducing life expectancy. Researchers have developed a gene therapy that may provide permanent relief for those suffering from DMD.
Read Original Article: New gene correction therapy for Duchenne muscular dystrophy »
